Recently, Duofu International Holding Group Co., Ltd. (hereinafter referred to as Duofu group) and Sinopharm Guohua Network Technology Co., Ltd. (hereinafter referred to as Sinopharm Guohua) reached a comprehensive and in-depth cooperation. At the beginning of the cooperation, the two sides will, in line with the principles of equality and mutual benefit, complementary advantages and coordinated development, give full play to their respective advantages in resources and science and technology in the industry, and jointly promote the implementation of the overall solution of smart medicine, the application of medical big data, and the landing of the national supply chain service platform.
Founded in 2003, Duofu group is a diversified group focusing on China's industrial development, with a total registered capital of more than 20 billion yuan. Its business covers five categories: real estate, trade, investment, industry, culture and tourism. With more than 10 years of experience, Duofu group has invested in more than 100 large-scale enterprises, and its industries cover domestic first and second tier core cities, Hong Kong, Singapore, Japan, Indonesia and other overseas regions. In 2019, Duofu group was selected as one of the top 500 private enterprises in China.
Sinopharm Guohua is an Internet high-tech enterprise affiliated to China Pharmaceutical Group Corporation, which focuses on the management of science and technology enabling industry. Its services cover the fields of medicine, education, government affairs, transportation, security, justice, etc. After 10 years of development, the company has become a group company that runs through the whole field of pharmaceutical industry, covers multiple scenes of public life, organically combines various plates, and develops cooperatively. Its enterprises have profound industry accumulation and innovative technology application in the fields of medical and health industry, pharmaceutical material procurement management, smart city and other fields.
Duofu group and Sinopharm Guohua will fully integrate resources and promote the business development of both sides. In this cooperation, the two sides take the establishment of a national scientific research material supply chain platform as the breakthrough point, create a supply chain financial system that meets the domestic development needs, and comprehensively serve the "release, management and service" of medical material procurement. At the same time, we are committed to building a complete health care big data industrial chain platform and building a closed-loop data value.
The cooperation between the two sides is expected to rebuild a new ecology of smart medicine and medical material procurement, and the commercial energy of both sides will be further released. Have a brilliant future in the Internet plus medical care and Internet plus supply chain finance through the unique supply chain service system and professional cold chain logistics distribution system.